Breaking News

Oxgene introduces TESSA technology for AAV manufacture

It aims to address challenges such as the high cost of goods, and low packaging efficiency

Optimus Holding completes acquisition of OM Pharma

An expansion of the manufacturing capacities at the site in Meyrin has already been decided and the project will start ...

Siemens DI supports Lianhetech Teesside plant expansion

Lianhetech serves the crop protection, pharmaceutical and performance markets

Utilising single-use technology in the biopharmaceutical industry

Since its inception, single-use technology has become more appealing because of its cost, minimal risk of cross- ...

Merck provides pre-seed funding to nanosyringe start up

The start up is engineering ‘nanosyringes’, a selective non-viral peptide and protein delivery system identified in ...

Analytical toolbox for cell and gene therapy development

Protagen Protein Services guides readers through the emerging field of gene therapy developments

Cleanroom Conference and Manufacturing Chemist Live 2020 to go virtual

The virtual event taking place on 10-11 November 2020 will provide delegates with full access to the Manufacturing ...

PharmaLex Group acquires BioStat Solutions

The merger diversifies PharmaLex’s existing statistical and data science service portfolio

Novacyt signs contract to supply PCR instruments to UK DHSC

This is the second major contract awarded by the DHSC to Primerdesign, Novacyt’s molecular diagnostics division, ...

Royal Society of Chemistry calls for R&D investment

The UK has fallen behind cohort nations in R&D investment, hampering efforts to boost productivity – with the impact ...

Transporting the COVID-19 vaccine around the world: a global problem

Elisabeth Vachette, Head of Product Management for Bags/Mixing/Tanks at Sartorius Stedim Biotech, discusses the ...

To build or buy: taking a pragmatic approach to outsourcing versus in-house manufacturing

A significant milestone in the life of any biotechnology company is deciding how to manufacture your biotherapeutic, ...

Sanofi completes Principia Biopharma acquisition

Principia Biopharma is now a wholly owned subsidiary of Sanofi

Catalent supports Nocion with blow-fill-seal technology

Catalent’s 430,000 sqft facility in Woodstock is the company’s location for sterile liquid fill/finish, leveraging ...

Inspiration and Learning